Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

11:43 EDT 22nd August 2014 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 7,900+

Tuesday 19th August 2014

Novel Human Tissue Samples Available For Research and Development

Tissue Access Will Advance New Treatments for Human Diseases Human tissues are extensively employed by pharmaceutical and academic researchers to identify and validate new biomarkers and drug discovery targets. Such tissues are also widely used to study the efficacy, reproducibility, and safety of experimental drug candidates against unmet clinical nee...

Reactivated Gene Sets Immune System Back 500M Years

Read more about Reactivated Gene Sets Immune System Back 500M Years

Development: Genome-wide association study reveals gene variants that are involved in the development of hypospadias

Roche and the Garvan Institute of Medical Research Partner to Develop Genomics Technologies for ...

Pleasanton, CA, USA, August 19, 2014 / B3C newswire / - Roche (SIX: RO, ROG; OTCQX: RHHBY) and the Garvan Institute of Medical Research today announce a collaboration to develop new technologies for targeted epigenomic analysis using DNA sequencing.  Genomics is a rapidly evolving field with a focus on realizing the potential use of sequencing information in patient diagnosis and treatment.&...

SomaLogic Announces Massachusetts General Hospital as First Boston-area Site for SOMAscan™ Proteomics Assay

SomaLogic, Inc., announced today that Massachusetts General Hospital (MGH) will be the first Boston-area biomedical research center to perform on-site studies using the SOMAscan™ assay, a breakthrough proteomics platform that can measure more than a thousand proteins in a small amount of blood or other biological sample. The SOMAscan assay will be perfor...

In-utero methadone or subutex exposure could alter gene expression, cause severe neonatal abstinence syndrome

Some infants born with neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure have a more difficult time going through withdrawal than others, but the underlying reasons are not well understood. While genetic and epigenetic (when ge...

Back to School With Confidence: Prevent Bullying of Kids With Asthma, Food Allergies

VIENNA, Va., Aug. 19, 2014 /PRNewswire-USNewswire/ -- Children with asthma and food allergies are vulnerable to bullying at school and online, often by classmates who tease or harass them because they're "different." It may be an age-old problem, but it must be addressed if we expect kids to be able to focus on their studies. Stopping confrontations before they start creates an environment where a...

New study shows how immune system developed in the course of evolution

Scientists at the Max Planck Institute of Immunobiology and Epigenetics (MPI-IE) in Freiburg re-activated expression of an ancient gene, which is not normally expressed in the mammalian immune system, and found that the animals developed a fish-like...

Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device

Breakthrough Medical Testing Platform Uses a Patient's Genetic Material to Make It Easier for Doctors to Match Patient and Optimal Treatment IRVINE, Calif. (PRWEB) August 19, 2014 Cellgen Diagnostics today launched an Indiegogo campaign to raise $200,000 to fund a corporate lab for its genetic-based medical testing and diagnostic device. This development is a critical component in the move f...

Dr Paul Blake becomes Chief Development Officer at Oxford BioMedica

Will take responsibility for the clinical development of pipeline of gene and cell therapies

Dr. Kevin Loughlin Joins DynaMed™ as Deputy Editor of Oncology and Hematology

Brigham and Women’s Doctor to Strengthen Oncology Content Available from the EBSCO Health Clinical Reference Tool Ipswich, MA (PRWEB) August 19, 2014 Healthcare professionals who access evidence-based oncology information through DynaMed™ will now be using content overseen by the new DynaMed Deputy Editor of Oncology and Hematology, Kevin Loughlin, MD, MBA, MA (Hon.). Dr. Loughlin brings exte...

How natural killer cells detect and destroy

Researchers have made inroads into better understanding the cytotoxic capacity of natural killer cells (NK cells) and hope to translate this into tackling cancers and other disorders. Dr Nick Huntington, Dr Priyanka Sathe and Ms Rebecca Delconte from the Walter and Eliza Hall Institute in Melbourne found that the MCL-1 protein is essential for the survival of NK cells. They suggest that MCL-...

7-Keto® Supplement Brand Sold to InterHealth

Leading Weight Loss Supplement Ingredient Humanetics Corporation (“Humanetics”), a leading researcher, developer and marketer of pharmaceuticals, medical foods and branded nutraceutical ingredients, announced today that it has sold its 7-Keto® dietary ingredient brand to InterHealth Nutraceuticals, Inc. of Benica, CA (“InterHealth”). 7-Keto®...

Akron Biotechnology, LLC Named 2014 Florida Companies to Watch Winner

Award Presented by GrowFL, in Association with the Edward Lowe Foundation Honors Upcoming Second-Stage Businesses throughout Florida Akron Biotechnology, LLC (Akron Biotech) is proud to be selected as one of fifty leading second-stage companies selected from more than 500 nominations statewide, as this year’s Florida Companies to WatchSM...

New Promega Branch in India Brings Convenient Access to Technologies and Support Services

Promega Corporation announces its expansion into India with a 16th branch that serves the country’s scientific community with wide product availability, efficient delivery and technical support services. Led by Dr. Rajnish Bharti, the Promega India team provides customers with industry-leading services and support, and rapid access to products and technologies. (...

Expression Analysis Announces 2014 Grant Program

Two recipients to receive cutting-edge services from EA and Illumina to advance new applications in oncology research Expression Analysis (EA), a Quintiles company, today announced that it is co-sponsoring a grant program that provides scientists with leading-edge products and services to advance genomics research. In the sixth year of the grant progra...

Dr. Rod Rohrich Explains the Importance of Volume Restoration in the Appearance of Youth

In the newly published book, "Navigate Your Beauty", Dallas plastic surgeon, Dr. Rod Rohrich, explains how volume restoration procedures such as fat grafting and fillers provide volume and help to restore the appearance of youth. Dallas, TX (PRWEB) August 19, 2014 In the recently published book, Navigate Your Beauty, Dallas plastic surgeon and professor of plastic surgery, Dr. Rod Rohri...

Innovations with Ed Begley Jr. to Showcase USCAP in Upcoming Episode

DMG Productions explores the latest breakthroughs in pathology and patient care. Evans, GA (PRWEB) August 19, 2014 USCAP announced today they will be featured in an upcoming episode of Innovations with Ed Begley Jr., slated to air later this year, 2014, via Discovery Channel. Dates and show times TBA. USCAP has been the global leader for advancing knowledge in the field of pathology for more than...

UPDATE: VistaGen Receives Notice of Allowance for Canadian Patent Further Expanding Stem Cell Technology Platform

VistaGen Therapeutics, Inc. (OTCQB: VSTAD), a biotechnology company applying pluripotent stem cell technology for drug rescue, drug discovery and regenerative medicine, today announces that the Canadian Intellectual Property Office has issued a Notice of Allowance for Canadian Patent Application No. 2,487,058, entitled "Mesoderm and Definitive Endoderm Cell Populations." This patent, which is lice...

Don't Optimize Your Plasma Protein Binding

Here's a very good review article in J. Med. Chem. on the topic of protein binding. For those outside the field, that's the phenomenon of drug compounds getting into the bloodstream and then sticking to one or more blood proteins. Human serum albumin...

New England Biolabs® Introduces New Ribosomal RNA Depletion Technology from Genomic Health

IPSWICH, Mass., Aug. 19, 2014 /PRNewswire/ -- New England Biolabs, Inc. (NEB®) today announced that NEB has exclusively in-licensed rights from Genomic Health, Inc. to its technology for the depletion of abundant RNAs, which is instrumental to performing sensitive RNA-seq experiments at a lower cost. Ribosomal RNAs (rRNAs) are extremely abundant, constituting approximately 90% of total...

Study: A Leading Herpes Drug Can Cause Kidney Damage; CBCD Recommends Novirin or Gene-Eden-VIR, Natural Herpes Remedies, With No Side Effects

A leading drug against the herpes virus can cause kidney damage and other side effects, according to a study published in the journal Pharmacoepidemiology and Drug Safety on April 30, 2014. (1) The CBCD reviews the medical evidence and recommends two natural herpes remedies. Rochester, NY (PRWEB) August 19, 2014 “Infected with the herpes virus (HSV-1 or HSV-2)? The CBCD recommends taking Noviri...

ValiRx happy with first half progress

Drug developer ValiRx (LON:VAL) is waiting for approval from the UK Ethics Committee to start recruitment for its first human trial of lead cancer treatment VAL201. The company ended the half year to June with cash equivalents of £0.76mln (2013...

VistaGen Receives Notice of Allowance for Canadian Patent Further Expanding Stem Cell Technology Platform

VistaGen Therapeutics, Inc. (OTCQB: VSTA), a biotechnology company applying pluripotent stem cell technology for drug rescue, drug discovery and regenerative medicine, today announces that the Canadian Intellectual Property Office has issued a Notice of Allowance for Canadian Patent Application No. 2,487,058, entitled "Mesoderm and Definitive Endoderm Cell Populations." This patent, which is licen...

Bioniche Announces Q1/2015 Timeline for the Filing of a Biologics License Application for Marketing Approval of MCNA in the United States

BELLEVILLE, ON, Aug. 19, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that it is targeting Q1/2015 for the filing of a Biologics License Application (BLA) with the United States Food and Drug Administration (FDA) for Bioniche's lead program Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) for the treatment of patients with high grade non-muscle invasive bladd...


Search BioPortfolio:
Advertisement
Advertisement

News Quicklinks